PVCs in the elderly: When to start worrying

Document Type

Journal Article

Publication Date

12-1-1985

Journal

Geriatrics

Volume

40

Issue

8

Abstract

Recent studies using electrophysiologic testing have established that effective antiarrhythmic therapy does indeed prolong survival in the high-risk group of survivors of out-of-hsopital cardiac arrest. Ideally, the initial antiarrhythmic agent is selected on the basis of its efficacy, side effects, ease of administration, cost, and interaction with other medications. To a large extent, however, selection remains empiric. In patients without QT prolongation, long-acting procainamide or quinidine are usually tried first.

This document is currently not available here.

Share

COinS